Cite
HARVARD Citation
Harter, P. et al. (n.d.). 18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial. International journal of gynecological cancer. pp. A13-A14. [Online].